Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors

Abstract

p300 and CREB-binding protein (CBP) are ubiquitously expressed pleiotropic lysine acetyltransferases and play a key role as transcriptional co-activators that are essential for a multitude of cellular processes. Despite great importance, there is a lack of highly selective, potent, druglike p300/CBP inhibitors. Through the artificial-intelligence-assisted drug discovery pipeline and further optimization, we reported the discovery of novel, highly selective, potent small-molecule inhibitors of p300/CBP histone acetyltransferases (HAT) with desired druglike properties, exemplified by B026 . Our data demonstrated that B026, with half maximal inhibitory concentration (IC 50 ) values of 1.8 nM to p300 and 9.5 nM to CBP enzyme inhibitory activity, is the most potent, selective p300/CBP HAT inhibitor. Moreover, B026 achieves significant and dose-dependent tumor growth inhibition in an animal model of human cancer, suggesting that B026 is a highly promising p300/CBP HAT inhibitor and warrants extensive preclinical investigation as a potential clinical development candidate.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.9b01721

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 50 · Cited by 132

Metadata

Authors
Yang, Y., Zhang, R., Li, Z., Mei, L., Wan, S., Ding, H., Chen, Z., Xing, J., Feng, H., Han, J., Jiang, H., Zheng, M., Luo, C., & Zhou, B.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Dezhou University (CN)
Corresponding author
  • Zheng, Mingyue
  • Luo, Cheng
  • Zhou, Bing
Venue
Journal of Medicinal Chemistry
Published
2020-01-07
Volume
63
Issue
3
Pages
1337-1360
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3000630658
Cited by
132
References
50
Citations by year
2026: 9 · 2025: 22 · 2024: 20 · 2023: 24 · 2022: 17 · 2021: 30 · 2020: 10
FWCI
6.97
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2017YFB0202604, 2018YFA0508200, 2018ZX09711002-004-012, 2018ZX09711002-004-013, 2018ZX09711002-006-001, 2018ZX09711002-008-005)
  • K. C. Wong Education Foundation
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences (2017333)
  • Science and Technology Commission of Shanghai Municipality (17QA1405000, 18431907100, 19XD1404700)
  • National Natural Science Foundation of China (21820102008, 81625022, 81773568, 81821005, 81973166, 91753207, 91853205)
  • Chinese Academy of Sciences (XDA12020361)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
P300, CREB-binding protein, histone acetyltransferase inhibitors, small molecule inhibitors, enzyme selectivity, oral bioavailability, tumor growth inhibition, cancer therapy
MeSH terms
Animals, Antineoplastic Agents, Enzyme Inhibitors, Female, Humans, Male, Mice, Inbred BALB C, Microsomes, Liver, Neoplasms, Spiro Compounds, Structure-Activity Relationship, Molecular Structure, Neural Networks, Computer, Rats, Sprague-Dawley, Cell Line, Tumor, Cell Proliferation, E1A-Associated p300 Protein, CREB-Binding Protein, Drug Discovery, Molecular Docking Simulation, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. https://app.cochat.ai/papers/10.1021/acs.jmedchem.9b01721
The paper
Yang, Y., Zhang, R., Li, Z., Mei, L., Wan, S., Ding, H., Chen, Z., Xing, J., Feng, H., Han, J., Jiang, H., Zheng, M., Luo, C., & Zhou, B. (2020). Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.9b01721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.